« Return to News | Awards & Advancement

Covance announces executive appointments

Friday, May 4, 2012 04:08 AM

Covance, a Princeton, N.J.-based provider of drug development services, has promoted Bill Klitgaard to corporate senior vice president and chief information officer, and Alison Cornell to corporate vice president and chief financial officer, effective May 8 upon approval by the board of directors.

Klitgaard has served Covance for 15 years, 12 of which as CFO—his most recent position. Informatics, an area of innovation for Covance that currently reports to Klitgaard, will be folded into the newly-expanded role of CIO.  As an executive sponsor of Covance's IT steering committee, Klitgaard played a critical leadership role in the development and funding of the company's major IT investments. Under his leadership, Covance implemented a complex, enterprise-wide finance system on time and on budget.  

Cornell joined Covance in 2004 from AT&T, where she served as financial vice president, forecasting, performance and investment analysis, heading finance for a $30 billion division. She was a key member of Covance’s clinical development leadership team from 2004 through 2010, serving as its finance leader, and played a critical role in transforming that business into a major growth driver for the company. She has been a driving force in the evaluation and lowering of our company's cost structure, and successfully designed and executed programs which have significantly lowered Covance’s DSOs. Most recently, Cornell served Covance as vice president of global financial planning and analysis, where she oversaw approximately 75% of the company's finance staff. 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.